TY - JOUR AU - Wong, T. Y. AU - Foster, P. J. AU - Hee, J. PY - 2000 DA - 2000// TI - Prevalence and risk factors for refractive errors in adult Chinese in Singapore JO - Invest Ophthalmol Vis Sci VL - 41 ID - Wong2000 ER - TY - JOUR AU - Wong, T. Y. AU - Ferreira, A. AU - Hughes, R. PY - 2014 DA - 2014// TI - Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review JO - Am J Ophthalmol VL - 157 UR - https://doi.org/10.1016/j.ajo.2013.08.010 DO - 10.1016/j.ajo.2013.08.010 ID - Wong2014 ER - TY - JOUR AU - Lam, D. S. C. AU - Chan, W. -. M. AU - Liu, D. T. PY - 2004 DA - 2004// TI - Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathological myopia in Chinese eyes: a prospective series of 1 and 2 year follow up JO - Br J Ophthalmol VL - 88 UR - https://doi.org/10.1136/bjo.2004.041624 DO - 10.1136/bjo.2004.041624 ID - Lam2004 ER - TY - JOUR PY - 2001 DA - 2001// TI - Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial—VIP report no. 1 JO - Ophthalmology VL - 108 UR - https://doi.org/10.1016/S0161-6420(01)00544-9 DO - 10.1016/S0161-6420(01)00544-9 ID - ref4 ER - TY - JOUR AU - Chan, W. M. AU - Ohji, M. AU - Lai, T. Y. PY - 2005 DA - 2005// TI - Choroidal neovascularization in pathological myopia: an update in management JO - Br J Ophthalmol VL - 89 UR - https://doi.org/10.1136/bjo.2005.074716 DO - 10.1136/bjo.2005.074716 ID - Chan2005 ER - TY - JOUR AU - Papadopoulos, N. AU - Martin, J. AU - Ruan, Q. PY - 2012 DA - 2012// TI - Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab JO - Angiogenesis VL - 15 UR - https://doi.org/10.1007/s10456-011-9249-6 DO - 10.1007/s10456-011-9249-6 ID - Papadopoulos2012 ER - TY - JOUR AU - Deissler, H. L. AU - Lang, G. K. AU - Lang, G. E. PY - 2014 DA - 2014// TI - Capacity of aflibercept to counteract VEGF-stimulated abnormal behaviour of retinal microvascular endothelial cells JO - Exp Eye Res VL - 122 UR - https://doi.org/10.1016/j.exer.2014.02.024 DO - 10.1016/j.exer.2014.02.024 ID - Deissler2014 ER - TY - JOUR AU - Wolf, S. AU - Balciuniene, V. J. AU - Laganovska, G. PY - 2014 DA - 2014// TI - RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2013.10.023 DO - 10.1016/j.ophtha.2013.10.023 ID - Wolf2014 ER - TY - JOUR AU - Ikuno, Y. AU - Ohno-Matsui, K. AU - Wong, T. Y. PY - 2015 DA - 2015// TI - Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study JO - Ophthalmology VL - 122 UR - https://doi.org/10.1016/j.ophtha.2015.01.025 DO - 10.1016/j.ophtha.2015.01.025 ID - Ikuno2015 ER - TY - JOUR AU - Chhablani, J. AU - Narayanan, R. AU - Mathai, A. PY - 2016 DA - 2016// TI - Short-term safety profile of intravitreal ziv-aflibercept JO - Retina VL - 36 UR - https://doi.org/10.1097/IAE.0000000000000913 DO - 10.1097/IAE.0000000000000913 ID - Chhablani2016 ER - TY - JOUR AU - Braimah, I. Z. AU - Stewart, M. AU - Videkar, C. AU - Dedhia, C. J. AU - Chhablani, J. PY - 2017 DA - 2017// TI - Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration JO - Br J Ophthalmol VL - 101 UR - https://doi.org/10.1136/bjophthalmol-2016-309994 DO - 10.1136/bjophthalmol-2016-309994 ID - Braimah2017 ER - TY - JOUR PY - 1993 DA - 1993// TI - Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials JO - Arch Ophthalmol VL - 111 UR - https://doi.org/10.1001/archopht.1993.01090090052019 DO - 10.1001/archopht.1993.01090090052019 ID - ref12 ER - TY - JOUR PY - 1994 DA - 1994// TI - Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity JO - Arch Ophthalmol VL - 112 UR - https://doi.org/10.1001/archopht.1994.01090160056023 DO - 10.1001/archopht.1994.01090160056023 ID - ref13 ER - TY - JOUR AU - Secretan, M. AU - Kuhn, D. AU - Soubrane, G. PY - 1997 DA - 1997// TI - Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment JO - Eur J Ophthalmol VL - 7 UR - https://doi.org/10.1177/112067219700700401 DO - 10.1177/112067219700700401 ID - Secretan1997 ER - TY - JOUR AU - Tano, Y. PY - 2002 DA - 2002// TI - Pathologic myopia: where are we now? JO - Am J Ophthalmol VL - 134 UR - https://doi.org/10.1016/S0002-9394(02)01883-4 DO - 10.1016/S0002-9394(02)01883-4 ID - Tano2002 ER - TY - JOUR AU - Virgili, G. AU - Menchini, F. PY - 2005 DA - 2005// TI - Laser photocoagulation for choroidal neovascularisation in pathologic myopia JO - Cochrane Database Syst Rev VL - 19 ID - Virgili2005 ER - TY - JOUR AU - Ruiz-Moreno, J. M. AU - Montero, J. A. PY - 2002 DA - 2002// TI - Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes JO - Eur J Ophthalmol VL - 12 UR - https://doi.org/10.1177/112067210201200207 DO - 10.1177/112067210201200207 ID - Ruiz-Moreno2002 ER - TY - JOUR AU - Blinder, K. J. AU - Blumenkranz, M. S. AU - Bressler, N. M. PY - 2003 DA - 2003// TI - Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial – VIP report no. 3 JO - Ophthalmology VL - 110 UR - https://doi.org/10.1016/S0161-6420(02)01998-X DO - 10.1016/S0161-6420(02)01998-X ID - Blinder2003 ER - TY - JOUR AU - Tan, C. S. AU - Chew, M. C. AU - Lim, T. H. PY - 2014 DA - 2014// TI - Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization JO - Eye (Lond) VL - 28 UR - https://doi.org/10.1038/eye.2013.204 DO - 10.1038/eye.2013.204 ID - Tan2014 ER - TY - JOUR AU - Baba, T. AU - Kubota-Taniai, M. PY - 2010 DA - 2010// TI - Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation JO - Br J Ophthalmol VL - 94 UR - https://doi.org/10.1136/bjo.2009.166025 DO - 10.1136/bjo.2009.166025 ID - Baba2010 ER - TY - JOUR AU - Arias, L. AU - Planas, N. AU - Prades, S. PY - 2008 DA - 2008// TI - Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results JO - Br J Ophthalmol VL - 92 UR - https://doi.org/10.1136/bjo.2007.130260 DO - 10.1136/bjo.2007.130260 ID - Arias2008 ER - TY - JOUR AU - Ikuno, Y. AU - Sayanagi, K. AU - Soga, K. PY - 2009 DA - 2009// TI - Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results JO - Am J Ophthalmol VL - 147 UR - https://doi.org/10.1016/j.ajo.2008.07.017 DO - 10.1016/j.ajo.2008.07.017 ID - Ikuno2009 ER - TY - JOUR AU - Tufail, A. AU - Patel, P. J. AU - Sivaprasad, S. PY - 2013 DA - 2013// TI - Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study JO - Eye (Lond) VL - 27 UR - https://doi.org/10.1038/eye.2013.8 DO - 10.1038/eye.2013.8 ID - Tufail2013 ER - TY - JOUR AU - Tufail, A. AU - Narendran, N. AU - Patel, P. J. PY - 2013 DA - 2013// TI - Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study JO - Ophthalmology VL - 120 UR - https://doi.org/10.1016/j.ophtha.2013.06.010 DO - 10.1016/j.ophtha.2013.06.010 ID - Tufail2013 ER - TY - JOUR AU - Lai, T. Y. AU - Chan, W. M. AU - Liu, D. T. PY - 2009 DA - 2009// TI - Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia JO - Retina VL - 29 UR - https://doi.org/10.1097/IAE.0b013e31819ed6bd DO - 10.1097/IAE.0b013e31819ed6bd ID - Lai2009 ER - TY - JOUR AU - Chen, Y. AU - Sharma, T. AU - Li, X. AU - Song, Y. AU - Chang, Q. AU - Lin, R. AU - Lai, T. Y. PY - 2019 DA - 2019// TI - Ranibizumab versus verteporfin photodynamic therapy in Asian patients with myopic choroidal neovascularization: BRILLIANCE, a 12-month, randomized, double-masked study JO - Retina (Philadelphia, Pa.) VL - 39 UR - https://doi.org/10.1097/IAE.0000000000002292 DO - 10.1097/IAE.0000000000002292 ID - Chen2019 ER - TY - JOUR AU - Hamilton, R. D. AU - Clemens, A. AU - Minnella, A. M. AU - Lai, T. Y. AU - Dai, H. AU - Sakamoto, T. PY - 2020 DA - 2020// TI - Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study JO - PLoS One VL - 15 UR - https://doi.org/10.1371/journal.pone.0227557 DO - 10.1371/journal.pone.0227557 ID - Hamilton2020 ER - TY - JOUR AU - Bruè, C. AU - Pazzaglia, A. AU - Mariotti, C. AU - Reibaldi, M. AU - Giovannini, A. PY - 2016 DA - 2016// TI - Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study JO - Eye (Lond) VL - 30 UR - https://doi.org/10.1038/eye.2015.199 DO - 10.1038/eye.2015.199 ID - Bruè2016 ER - TY - JOUR AU - Pece, A. AU - Milani, P. PY - 2016 DA - 2016// TI - Intravitreal aflibercept for myopic choroidal neovascularization JO - Graefes Arch ClinExp Ophthalmol VL - 254 UR - https://doi.org/10.1007/s00417-016-3396-9 DO - 10.1007/s00417-016-3396-9 ID - Pece2016 ER - TY - JOUR AU - Yoshida, T. AU - Kyoko Ohno-Matsui, K. PY - 2002 DA - 2002// TI - Long-term visual prognosis of choroidal neovascularization in high myopia. A comparison between age groups JO - Ophthalmology VL - 109 UR - https://doi.org/10.1016/S0161-6420(01)01007-7 DO - 10.1016/S0161-6420(01)01007-7 ID - Yoshida2002 ER - TY - JOUR AU - Holz, F. G. AU - Tufail, A. AU - Leveziel, N. AU - Lai, T. Y. AU - Lanzetta, P. AU - Wong, T. Y. PY - 2016 DA - 2016// TI - Ranibizumab in myopic choroidal neovascularization: a subgroup analysis by ethnicity, age, and ocular characteristics in RADIANCE JO - Ophthalmologica VL - 236 UR - https://doi.org/10.1159/000446027 DO - 10.1159/000446027 ID - Holz2016 ER - TY - JOUR AU - Mansour, A. M. AU - Ashraf, M. AU - Charbaji, A. PY - 2018 DA - 2018// TI - Two-year outcomes of intravitreal ziv-aflibercept JO - B J Ophthalmol VL - 102 UR - https://doi.org/10.1136/bjophthalmol-2017-311591 DO - 10.1136/bjophthalmol-2017-311591 ID - Mansour2018 ER - TY - JOUR PY - 2019 DA - 2019// TI - Safety of 5914 intravitreal ziv-aflibercept injections JO - Br J Ophthalmol VL - 103 UR - https://doi.org/10.1136/bjophthalmol-2018-312453 DO - 10.1136/bjophthalmol-2018-312453 ID - ref33 ER - TY - JOUR AU - Chhablani, J. AU - Dedhia, C. J. AU - Peguda, H. K. AU - Stewart, M. PY - 2017 DA - 2017// TI - Short-term safety of 2mg intravitreal ziv-aflibercept JO - Retina (Philadelphia, Pa) VL - 37 UR - https://doi.org/10.1097/IAE.0000000000001440 DO - 10.1097/IAE.0000000000001440 ID - Chhablani2017 ER - TY - JOUR AU - Mansour, A. M. AU - Al-Ghadban, S. I. AU - Yunis, M. H. AU - El-Sabban, M. E. PY - 2015 DA - 2015// TI - Ziv-aflibercept in macular disease JO - Br J Ophthalmol VL - 99 UR - https://doi.org/10.1136/bjophthalmol-2014-306319 DO - 10.1136/bjophthalmol-2014-306319 ID - Mansour2015 ER - TY - JOUR AU - Singh, S. R. AU - Dogra, A. AU - Stewart, M. AU - Das, T. AU - Chhablani, J. PY - 2017 DA - 2017// TI - Intravitreal ziv-aflibercept: clinical effects and economic impact JO - Asia Pac J Ophthalmol (Phila) VL - 6 UR - https://doi.org/10.22608/APO2017416 DO - 10.22608/APO2017416 ID - Singh2017 ER - TY - JOUR AU - Ross, E. L. AU - Hutton, D. W. AU - Stein, J. D. AU - Bressler, N. M. AU - Jampol, L. M. AU - Glassman, A. R. PY - 2016 DA - 2016// TI - Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment: Analysis from the diabetic retinopathy clinical research network comparative effectiveness trial JO - JAMA Ophthalmol VL - 134 UR - https://doi.org/10.1001/jamaophthalmol.2016.1669 DO - 10.1001/jamaophthalmol.2016.1669 ID - Ross2016 ER -